PRESS RELEASE published on 09/16/2026 at 22:00, 1 month 23 days ago Inside Information / Other news releases Innate Pharma and Sobi partnership becomes effective after meeting closing conditions, triggering USD 75 million payment and commencing TELLOMAK-3 Phase 3 study in Q1 2027 Partnership Innate Pharma Closing Conditions Sobi TELLOMAK-3
BRIEF published on 09/10/2026 at 07:05, 2 months ago Innate Pharma fournira des informations financières lors de sa prochaine conférence téléphonique. Stratégie D'entreprise Conférence Téléphonique Mise À Jour Financière Innate Pharma Résultats 2026
BRIEF published on 09/10/2026 at 07:05, 2 months ago Innate Pharma to Provide Financial Insights in Upcoming Conference Call Conference Call Business Strategy Financial Update Innate Pharma 2026 Results
BRIEF published on 09/10/2026 at 07:05, 2 months ago Innate Pharma annonce une conférence sur ses résultats semestriels Résultats Financiers Immunothérapie Conférence Téléphonique Partenariats Biopharmaceutiques Innate Pharma
BRIEF published on 09/10/2026 at 07:05, 2 months ago Innate Pharma announces a conference on its half-year results Financial Results Conference Call Immunotherapy Innate Pharma Biopharmaceutical Partnerships
PRESS RELEASE published on 09/10/2026 at 07:00, 2 months ago Inside Information / Other news releases Innate Pharma to host conference call on September 17, 2026, providing first half 2026 financial results and business update. Event details available on www.innate-pharma.com Financial Results Conference Call Biotechnology Business Update Innate Pharma
PRESS RELEASE published on 09/10/2026 at 07:00, 2 months ago Informations privilégiées / Autres communiqués Innate Pharma organise une conférence téléphonique et un webcast le 17 septembre pour présenter ses résultats financiers et son activité au premier semestre 2026 Résultats Financiers Webcast Conférence Téléphonique Innate Pharma Immunothérapies
BRIEF published on 08/14/2026 at 11:35, 2 months 27 days ago Innate Pharma Announces Upcoming Conference Call and Webcast Conference Call Biotechnology Webcast Immunotherapy Innate Pharma
BRIEF published on 08/14/2026 at 11:35, 2 months 27 days ago Innate Pharma annonce une conférence téléphonique et une webdiffusion à venir Biotechnologie Immunothérapie Webdiffusion Conférence Téléphonique Innate Pharma
PRESS RELEASE published on 08/14/2026 at 11:30, 2 months 27 days ago Inside Information / Other news releases Innate Pharma to host conference call and webcast with key executives discussing latest updates. Event details available on company website Conference Call Biotechnology Webcast Immunotherapy Innate Pharma
Published on 11/10/2026 at 14:45, 6 hours 16 minutes ago An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 6 hours 30 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 6 hours 31 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 6 hours 31 minutes ago ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 14:00, 7 hours 1 minute ago Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
Published on 11/10/2026 at 19:21, 1 hour 40 minutes ago ALTHEORA, Mäder Composites France et IPC s'associent pour donner une seconde vie aux matériaux composites
Published on 11/10/2026 at 18:54, 2 hours 6 minutes ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 18:45, 2 hours 16 minutes ago Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications
Published on 11/10/2026 at 18:30, 2 hours 31 minutes ago Shelly Group Accelerates Revenue Growth in the Third Quarter and Confirms Full-Year 2026 Guidance
Published on 11/10/2026 at 18:00, 3 hours 1 minute ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 3 hours 16 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 3 hours 26 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 3 hours 29 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
